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Although acute infection of feline foamy virus (FeFV) is normally highly cytopathogenic in Crandell feline kidney (CRFK)
cells, a noncytopathic persistent infection was established in the cells after cocultivation of the initially infected cells with
uninfected cells four times. To investigate reactivation of persistent infection, CRFK cells chronically infected with FeFV were
treated with trichostatin A (TA), a histone deacetylase inhibitor. TA induced higher FeFV production from the Coleman strain
carrier culture and also induced marked syncytium formation. In contrast, human foamy virus, which contains less
homologous long terminal repeat (LTR) and putative internal promoter (IP) sequences, persistently infecting baby hamster
kidney cells was not reactivated by TA. The Sammy-1 strain of FeFV, from which a part of the U3 region in the LTR is naturally
deleted, showed less reactivation. The Coleman LTR promoter-based b-Gal-expressing plasmid was activated in the
persistently Coleman-infected cells in the presence of TA, whereas the Sammy-1 LTR was not activated. Furthermore, the
amounts of Gag protein expressed did not change in the presence or absence of TA. Because the putative IP region was very
similar between the two strains, the initiation by TA is relatively specific for LTR sequences, and, therefore, histone
deacetylation is at least in part responsible for reactivation of FeFV from carrier cell culture. © 2001 Academic PressINTRODUCTION
Foamy viruses (FVs) have been isolated from a large
number of mammalian species (Malmquist et al., 1969;
Riggs et al., 1969; Kennedy-Stoskopf et al., 1986; Achong
et al., 1971; Hooks and Gibbs, 1975; Hruska and Take-
moto, 1975; Flanagan, 1992). The feline foamy virus
(FeFV), which is classified as a member of the genus
Spumavirus of family Retroviridae, was first isolated in
969 (Kasza et al., 1969); several strains of FeFV and
eFV-related viruses have been reported since then
Riggs et al., 1969; Mochizuki and Konishi, 1979; Ikeda et
l., 1997). Most of the FVs are highly cytopathogenic,
eading to cell death in vitro (Kasza et al., 1969; Mergia et
l., 1996; Mikovits et al., 1996); however, paradoxically,
ersistently infected cells have been established in vitro
ithout cell death (Ikeda et al., 1997). The mechanisms of
ersistent infection with FeFV are not yet understood.
For FV transcription, Bel-1 protein is known to be
bsolutely required as a transactivator (Tas), similar to
at of HIV (Baunach et al., 1993). A putative Tas-specific
binding site was found in both the human foamy virus
1 To whom reprint requests should be addressed at the Department
f Veterinary Microbiology, Graduate School of Agricultural and Life
ciences, University of Tokyo, 113-8657 Tokyo, Japan. Fax: 181-3-5841-
184. E-mail: aeiji@mail.ecc.u-tokyo.ac.jp.
315(HFV) long terminal repeat (LTR) and internal promoter
(IP), but the elements have little sequence identity (Kang
et al., 1998). Tas transcription is initially induced by IP
(Yang et al., 1997). Once the level of Tas is upregulated,
the IP is switched to using the LTR promoter for control-
ling transcription of the structural genes (Kang et al.,
1998). However, Tas is not found in viral particles. Thus,
after chronic FV infection, the reactivation mechanism is
still unknown.
Recent investigations have revealed that histone
acetyltransferases are critical in activating and silencing
promoter activities by altering the chromatin structure
(Pfeffer and Vidali, 1991). Trichostatin A (TA) is a specific
inhibitor of histone deacetylases (Yoshida et al., 1990). TA
has no effect on HIV-1 retroviral promoter activity when
HIV promoter-reporter plasmids are unintegrated (Lint et
al., 1996). However, upon integration, TA activates HIV-1
transcription (Sheridan et al., 1997) as well as human
papillomavirus promoter activity (Zhao et al., 1999) and
expression of a transduced adenovirus promoter–lacZ
gene (Chen et al., 1997). These reports suggest that TA is
a useful tool for highly expressing some transduced
genes. Early studies, in which FVs were applied as gene
delivery vehicles (Bieniasz et al., 1997; Schmidt and
Rethwilm, 1995; Russell and Miller, 1996), were carried
out despite the fact that the infectious virus titers were
0042-6822/01 $35.00
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316 HATAMA ET AL.marginal (Schmidt and Rethwilm, 1995; Bieniasz et al.,
1997); however, as yet there have been no studies of
whether TA regulates the FV promoter.
Because of the proposed use of FeFV vectors for gene
therapy (Bieniasz et al., 1997) and elucidation of initiation
of FV infection (Yu et al., 1996), it is of interest to deter-
mine whether treatment with TA could be responsible for
the enhancement of FeFV replication. In this study we
therefore examined whether TA can break the persistent
state of FeFV-infected cells and also considered which
factors may be related to the chronicity of FeFV infection.
RESULTS
Reactivation of FeFV production from carrier cell
culture by treatment with TA
To determine whether the inhibition of histone
deacetylation was the cause of reactivation of FeFV, we
treated each of three FeFVs (Coleman, S7801, and
Sammy-1 strains) and HFV carrier Crandell feline kidney
(CRFK) and baby hamster kidney (BHK) cells, respec-
tively, with titrated amounts of TA for 3 days (0.3 nM to 3
mM). Viral titers in the culture supernatant were deter-
mined as 50% tissue culture infective dose (TCID50) by
he cytopathic effect (CPE) assay. Although the viral titer
as initially low in the supernatant of carrier culture, the
A treatment raised the viral production from the
oleman-carrying cells in a dose-dependent manner (Ta-
le 1). However, this reagent was not so effective against
7801, Sammy-1 (Table 1), and HFV (data not shown).
Furthermore, after the treatment with TA, CRFK cells
ersistently infected with Coleman virus were stained
ith May–Gru¨nwald–Giemsa and were examined micro-
copically. The morphology of carrier cell cultures was
ramatically changed by TA treatment. TA-treated
oleman carrier culture exhibited marked CPE with large
yncytia (Figs. 1D, 1E, and 1F), very different from cul-
ures not treated with TA (Fig. 1C) or control CRFK cells
TABLE 1
Reactivation of FeFV Strains in CRFK Cells by Treatment with TA
TA dilution
Persistent infection Acute infection
Coleman S7801 Sammy-1 Coleman
1024 4.5 6 0.3 1.5 6 0.1 1.3 6 0.3 NT
1025 2.3 6 0.2 1.0 6 0.2 1.2 6 0.3 NT
1026 1.2 6 0.2 1.0 6 0.3 0.8 6 0.1 NT
1027 1.2 6 0.4 1.0 6 0.3 0.7 6 0.2 NT
1028 1.0 6 0.2 0.8 6 0.2 0.8 6 0.2 NT
0 0.8 6 0.1 0.8 6 0.2 0.7 6 0.2 2.5 6 0.2
Note. The experiment was repeated three times. Values are repre-
ented as mean virus titers by log10 TCID50/ml. 10
24 5 3 mM TA
concentration; NT, not tested.Figs. 1A and 1B). However, we could not find any mor- mhological changes in S7801 and Sammy-1 carrier cul-
ures (data not shown).
We also examined the effect of TA treatment by re-
erse transcriptase (RT) assays as described under Ma-
erials and Methods. Virion-associated RT activity in the
oleman carrier culture supernatant increased from
50 6 10 to 1433 6 21 dpm with the treatment of 3 mM
A, while RT activity of S7801 and Sammy-1 did not show
ny significant increase (from 603 6 40 to 846 6 36 and
rom 520 6 26 to 487 6 30, respectively). As a negative
ontrol, RT activity in the supernatant of CRFK culture
as 64 6 4 dpm.
To compare the effect of other reagents on viral reac-
ivation, we treated the cells with 59-azacytidine, which
as been used to reactivate endogenous genes the pro-
oters and enhancers of which are methylated (Fergu-
on et al., 1995; Lee et al., 1995; Yoshiura et al., 1995).
his reagent slightly reactivated viral production from all
ines (Table 2). However, the reactivity is rather low
ompared with TA treatment of the coleman strain. In
ontrast, treatment with sodium butyrate, which inhibits
istone deacetylases and has a number of other activi-
ies (Kruh, 1982), did not reactivate viral production at a
oncentration of 50 mM (Table 2). Initial tests performed
ith a broad range of sodium butyrate concentrations
ielded similar results (data not shown). These results
uggest that the mechanism for reactivation of viral
ransgenes may be different from the activation of some
ndogenous genes. Thus, histone acetylation is likely to
FIG. 1. Morphological alterations of FeFV-infected CRFK cells caused
by TA treatment. CRFK cells persistently infected with Coleman (C to F)
or mock-infected (A and B) were treated with TA for 3 days at a
concentration of 3 mM (B, D, and F) or 0.3 nM (E) or were left untreated
A and C). After May–Gru¨nwald–Giemsa staining, cells were examinedicroscopically. Magnifications: A to E, 3100; F, 3200.
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317CHRONIC INFECTION OF FELINE FOAMY VIRUSdirect viral production in the initial phase of replication in
the chronically infected cells, but sensitivity to the acety-
lase reagent is different among the three viral strains.
Partial deletion of U3 in the LTR sequence of FeFV
The proviral nucleotide sequence of the FeFV long
terminal repeat (LTR) region was analyzed and com-
pared among the three different FeFV strains (Coleman,
S7801, and Sammy-1) aligned with the sequence of FUV
prototype strain (Fig. 2). The Coleman LTR was 1390
nucleotides long and corresponds to the FUV LTR. Ho-
mology of nucleic acid sequences between Coleman
LTR and FUV and HFV LTRs was 97.7 and 47.1%, respec-
tively. On the other hand, S7801 and Sammy-1 LTRs were
different from the FUV LTR in length (1372 and 1371
nucleotides). Although the putative transcriptional factor
binding motifs, such as heat-shock transcription factor
and AP-1 transcription factor, are conserved in the LTR
promoter region, we found a deletion in the U3 region of
S7801 and Sammy-1 (from nt 615 to nt 641) (Fig. 2). We
also examined the nucleotide sequence of putative in-
ternal promoter regions among the three strains, but did
not find any significant differences (data not shown). The
HFV LTR did not contain homologous DNA sequences
corresponding to the deleted region in the U3 of S7801
and Sammy-1 LTRs. From these data, it is concluded that
FeFV reactivation by TA treatment is LTR-specific and
dependent on this deleted promoter element.
To investigate reactivity of Tas against the LTR pro-
moter caused by TA treatment, b-galactosidase (b-Gal)
ssays were performed. Three LTR reporter plasmids
erived from Coleman, S7801, and Sammy-1 FeFV strains
ere transiently transfected into FeFV carrier cells. TA
ntensively induced high FeFV promoter activity of
oleman LTR–b-gal reporter in Coleman carrier cultures.
In contrast, LTR of the other two strains did not (Table 3).
S7801 and Sammy-1 LTRs were slightly activated by TA
in their own virus carrier cultures (Table 3). Control pSV
promoters were not activated by Tas in the presence or
the absence of TA (Table 3). These data suggest that Tas
is crucial to viral transcription and that TA enhances the
TABLE 2
Reactivation of FeFV in Persistently Infected Cells after Treatment
with 5-Azacytidine and Sodium Butyrate
Virus strain 5-Azacytidine Butyrate None
Coleman 1.8 6 0.2 0.8 6 0.1 0.8 6 0.1
S7801 1.8 6 0.3 0.7 6 0.2 0.8 6 0.2
Sammy-1 1.5 6 0.2 0.8 6 0.2 0.7 6 0.2
Note. The experiment was repeated three times. Values are pre-
ented as mean virus titers by log10 TCID50/ml. Concentrations of
-azacytidine and butyrate are 3 mM or 50 mM, respectively.transactivation in an LTR-dependent manner.Gag expression and morphology of viral structure
in FeFV
We examined viral protein expression in the carrier
culture with or without TA treatment by immunoblotting
(Fig. 3). The lysates of three FeFV carrier cells were
subjected to SDS–PAGE, transferred to membranes, and
stained with FeFV-infected cat serum. An approximately
53-kDa band corresponding to Gag was observed in all
the carrier cells. The CRFK cells as a negative control did
not show any positive bands (Fig. 3). Unexpectedly, ex-
pression levels of Gag proteins in the presence of TA
(Fig. 3, lane 3 of Coleman, lane 5 of S7801, and lane 7 of
Sammy-1) were the same as in its absence (Fig. 3, lane
4 of Coleman, lane 6 of S7801, and lane 8 of Sammy-1).
Bands of approximately 48 kDa, which were thought to
be a processed Gag protein, were also found in the
Coleman and S7801 carrier cells, but not in Sammy-1
(Fig. 3).
Electron microscopy (EM) was used to examine the
budding of FeFV particles from the plasma membrane
after treatment with TA. The numbers of budded
Coleman and S7801 particles were increased to hun-
dreds of virions per electron microscopic area by TA
treatment, but this was not observed in cells infected
with the Sammy-1 strain. Cells infected with Coleman
virus accumulated intracellular naked viral capsids (Fig.
4). Interestingly, Coleman particles contained spike-like
structures, probably representing envelope protein,
whereas S7801 and Sammy-1 possessed multimem-
brane-enclosed particles, with no spike appearance,
containing an electron-dense viral core (Fig. 4). These
particles were not observed in the control CRFK cells
(Fig. 4).
DISCUSSION
In this study, we show that TA treatment induces viral
production at a higher titer from the carrier culture of
FeFV/CRFK. Chen et al. (1997) have recently demon-
strated that the treatment with 5-azacytidine and sodium
butyrate significantly increased reactivation of adenovi-
rus promoter–lacZ gene expression. In addition, both
human and simian FVs have been reported to be reac-
tivated by 5-azacytidine (Hoota and Loh, 1987; Schweizer
et al., 1993), and TA reactivates HIV-1 transcription
(Sheridan et al., 1997). Although butyrate showed less
reactivation than TA, these data suggest that histone
deacetylation is important for reactivation of FeFV.
The Japanese isolates, S7801 and Sammy-1, contained
deletions in the 59-LTR promoter U3 regions compared
with the American isolate, Coleman (Fig. 2). HFV variants
with the largest U3 deletions showed low ability to rep-
licate in human cell cultures (Schmidt et al., 1997). In
addition, the nucleic acid sequences of the putative IP
region and the U5 region of the FeFV and HFV LTRs were
conserved (Kang et al., 1998), suggesting that deletion of
d as so
318 HATAMA ET AL.the U3 promoter region is related to the reactivation of
FeFV in vitro.
The Bel-1 protein has been reported to be an essential
requirement for LTR- and IP-mediated FV transcription
FIG. 2. Genome organization and alignment of the nucleotide sequen
among three FeFV strains (Coleman, S7801, and Sammy-1) are present
respect to the start of the U3 region of the 59-LTR. Numbers in the align
Deletions in the U3 promoter region in the 59-LTR are boxed. The end
Transcriptional factor binding motifs in the promoter region are marke(Baunach et al., 1993). Our results strongly support theview that the presence of Bel-1 is absolutely necessary
for LTR-mediated transcription. Interestingly, the level of
expression of Gag was not altered by treatment with TA,
and no difference in the amounts of Gag mRNA was
e promoter-enhancer region in FeFV. The complete 59-LTR sequences
the prototype FeFV FUV sequence. The scale at the top is drawn with
f the sequences represent distances along the genome in base pairs.
3, R, and U5 regions are represented by solid arrowheads with bars.
lid arrows.ce of th
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319CHRONIC INFECTION OF FELINE FOAMY VIRUSPCR (unpublished data). Further, in the presence or ab-
sence of TA, Hirt’s extracted DNA copies (Hirt, 1967) of
Coleman carrier cells were equivalent to those of S7801
carrier cells. These data suggest that TA treatment has
no effect on the accumulation of unintegrated FeFV DNA
and that TA could only change initiation of Bel-1. It has
been reported that Bel-1-defective forms of HFV provi-
FIG. 2ruses can prevent cell lysis and lead to persistent infec-tion (Saib et al., 1993). Histone deacetylation by TA is
ikely to direct initiation of Bel-1 expression and LTR
eletion may be related to this initiation. Thus, initiation
f FeFV reactivation by TA may involve the deleted ele-
ent of the U3 promoter. Investigations of the precise
egion spanning the putative regulator element are cur-
ently underway.
inuedIn the case of the Sammy-1 strain, Gag protein did not
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320 HATAMA ET AL.appear to be efficiently cleaved. Because it has been
suggested that processing of Gag has a critical role in
infecting host cells, infection of progeny virus to new
cells in vitro may be related to Gag cleavage by protease.
Therefore, viral particles might have been rarely detected
in persistently infected cells in EM analysis. Although
spike-less alteration of FV morphology has been ob-
served in chimeric FVs (Pietschmann et al., 1999), our
results indicate the possibility of an alteration in the viral
construct of Sammy-1. The morphological alteration is
likely to cause incomplete cleavage of the Gag protein
and the uncleaved Gag may also contribute to the per-
sistent state via a lesser infectivity of viral particles;
however, more precise examination needs to be done to
define viral capsid construction.
MATERIALS AND METHODS
Viruses and cells
Three FeFV strains, American isolate Coleman (Ikeda
et al., 1997) and Japanese isolates S7801 (Mochizuki and
Konishi, 1979) and Sammy-1 (Miyazawa et al., 1995),
were obtained as described previously. The HFV strain,
HS007 (Adachi et al., 1995), was a kind gift of Dr. A.
dachi. RT nonproducing cells derived from CRFK (ATCC
CL 94) (Crandell et al., 1973), designated NV112, were
T
Activation of FeFV LTR Promoter-Based b-gal Repo
Transactivator
b-Gal-e
Coleman LTR
Coleman 104 6 6/68 6 10*
S7801 56 6 2/35 6 8*
Sammy-1 17 6 2/14 6 3
Note. The number of positive cells was counted by microscopic ana
* P , 0.01.
FIG. 3. Detection of Gag-specific proteins in FeFV carrier cells. CRFK
cells persistently infected with Coleman (lanes 3 and 4), S7801 (lanes
5 and 6), or Sammy-1 (lanes 7 and 8) strains or mock-infected (lanes 1
and 2) were treated with TA or left untreated. After three days of
incubation, cells were harvested, electrophoresed by SDS–PAGE, and
analyzed by immunoblotting with FeFV Coleman-infected cat serum.
The molecular masses of proteins are given in the left margin.ubcloned and used for CPE and b-Gal assays. CRFK
cells persistently infected with FeFVs were established
as described previously (Miyazawa et al., 1995) and were
cultivated in Iscove’s modified Dulbecco’s medium
(Gibco. Grand Island, NY) supplemented with 10% heat-
inactivated fetal bovine serum and antibiotics.
Viral titration
Twofold serial dilutions of the supernatant (100 ml)
rom the infected cell culture were added to cells seeded
n a 96-well plate as described previously (Ikeda et al.,
997). After cells were passaged two times at 6-day
ntervals, infection by FeFV was judged by the CPE ob-
erved by microscopy. The virus titers are presented at
he 50% TCID50.
RT assay
Virion-associated reverse transcriptase RT activity
was measured with 2.5 mCi of [methyl-3H]deoxythymi-
dine 59-triphosphate with 2 mM Mn21 by the method of
Johnson et al. (Johnson et al., 1989).
Plasmid constructs and b-Gal assay
The LTR region was amplified from total RNA extracted
from FeFV carrier cell cultures by PCR (primer F, TC-
CAAGTGATGTTGCTTCCC; and primer R, CAGTAAGGTA-
AGGTCCCTAG) using LA-Taq polymerase (Takara, Kyoto,
Japan) and inserted into the pCR2.1 TA cloning vector
(pCR/LTR1 of Coleman, pCR/LTR2 of S7801, and pCR/
LTR3 of Sammy-1). The DNA was automatically se-
quenced by M13 primer using a DSQ-2000L machine
(Shimazu, Tokyo, Japan). The sequences of Coleman,
S7801, and Sammy-1 LTRs described here have been
submitted to DNA Data Bank of Japan with the following
accession numbers: AB042566, AB042567, and
AB042568, respectively. The Accession No. of the FUV
LTR used here is Y08851. FeFV enhancer and promoter-
directed b-Gal expression plasmids (pSV/LTR-1, pSV/
LTR-2, pSV/LTR-3) were constructed by introducing the
asmids on FeFV/CRFK Cells by Treatment with TA
ng plasmids
pSV-bgal1 LTR Sammy-1 LTR
/87 6 2 89 6 5/80 6 4 0/0
/20 6 3 25 6 3/29 6 3 0/0
/14 6 1 15 6 1/9 6 1 0/0
fter b-galactosidase staining. The sets of figures are TA1/TA2.ABLE 3
rter Pl
xpressi
S780
44 6 8
28 6 4
8 6 1
lysis a1.4-kb EcoRI (blunted) fragment of pCR/LTR1-3 into pSV-
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321CHRONIC INFECTION OF FELINE FOAMY VIRUSbgal cut by HindIII (blunted). All plasmids were prepared
for b-Gal assays by alkaline lysis and purification by
esium chloride centrifugation. Transient transfection
nto the FeFV carrier cells was performed using the
ipofectin liposomal transfection reagent as specified by
he manufacturer (Life Technologies, Germany). Briefly,
ubconfluent cells in 60-mm-diameter plates were trans-
ected with 5 mg of total plasmid DNA and 25 ml of
lipofectin (GIBCO) as described previously (Fujii et al.,
1996). For b-Gal assays, cells were fixed in 0.5% glutar-
aldehyde and stained with 2% X-Gal (Takara) substrate
with 50 mM potassium ferri/ferrocyanide buffer. Specific
activation of LTR was calculated as follows; specific
activity of b-Gal 5 positive cell numbers of experimental
ample 2 the spontaneously positive cell number of the
ontrol sample. Spontaneous activation was measured
y transfection of LTR–b-Gal plasmids alone into unin-
ected CRFK cells. The values shown are the means 6
D of at least three independent transfections.
Profiles of transcription factor binding sites were an-
FIG. 4. Electron micrographs of FeFV persistently infected CRFK cell
of TA or were untreated. After 3 days, cells were fixed and then subjec
Control).lyzed by TFSEARCH ver. 1.3 in the GenomeNet web site.mmunoblotting
Electrophoresis was performed in 10% polyacrylamide
els containing 0.1% SDS. After transfer to polyvinylidene
ifluoride membranes (Millipore, MA), the blotted pro-
eins were blocked with 5% dry milk in PBS with 0.1%
P-40 overnight. Anti-FeFV and control feline sera ob-
ained from FeFV-infected and specific-pathogen-free
ats were used as a first antibody, and anti-cat IgG
onjugated to the alkaline phosphatase (Boehringer-
annheim, Germany) was used as the secondary anti-
ody. The membrane was stained as described previ-
usly (Otake et al., 1994).
Electron microscopic analysis
FeFV-infected and uninfected cells were washed
and fixed in 2% glutaraldehyde followed by 0.1 M
phosphate buffer (pH 7.2) containing 2% osmium tet-
roxide. Samples were then stained with 1% uranyl
acetate, dehydrated with a graded series of ethanol
Coleman, S7801, and Sammy-1 carrier cells were treated with 50 mM
lectron microscopy. Scale bar, 200 nm (FeFV-infected cells) and 1 mms. FeFV
ted to edilutions followed by 100% ethanol propylene oxide,
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322 HATAMA ET AL.and embedded in epoxy resin. Thin sections were
cut and stained with lead citrate. The sections
were viewed and photographed using a JEOL Model
1200 EX.
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